Comments to FDA: Significant Scientific Agreement Share page: Docket Number: 99D-5424 CHPA submits these written comments in response to FDA’s notice in the Federal Register concerning “Guidance for Industry: Significant Scientific Agreement in the Review of Health Claims for Conventional Foods and Dietary Supplements.” Download Document Issues: Dietary Supplements Other Issues Research Related Posts Polibrief Per-and Polyfluoroalkyl Substances (PFAS) Nov 20, 2024 Polibrief Weight Loss Products Nov 20, 2024 Polibrief OTC Sales Tax Exemptions Nov 19, 2024